Article
Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
Neurology - 10 Oct 2006
Müller J S, Baumeister S K, Rasic V M, Krause S, Todorovic S, Kugler K, Müller-Felber W, Abicht A, Lochmüller H
Abstract excerpt
OBJECTIVE: Congenital myasthenic syndromes (CMS) with underlying RAPSN mutations turned out to be of high clinical relevance due to their worldwide frequency. To date, all reported patients with CMS with sequence variations in the translated region of RAPSN carry the mutation N88K on at least one allele. The authors report two patients lacking the common N88K allele but harboring differing novel mutations of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
